IC 303
"Hype, Promise, and Reality: Orthopedic Use of Biologics in 2023"
Course Description:
This ICL will cover the most recent updates regarding the uses of orthobiologics in the management of orthopedic patients. Covered will be regulatory aspects of orthobiologics, basic science and clinical evidence in the treatment of osteoarthritis and soft tissue restoration, and strategies for billing in the use of orthobiologics. The presentations are as follows:
Learning Objectives:
Faculty:
Stephen C. Weber, MD
Jason L. Dragoo, MD
Louis F. McIntyre, MD
Scott A. Rodeo, MD